Calithera Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights

    NEXT STORY
    Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study
    PREV STORY
    Chiasma Reports Second Quarter 2020 Results and Significant Progress on Launch Preparedness
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immutep Completes Recruitment of Head and Neck Cancer Patients of Phase II TACTI-002 Study

    author_avatar
    NASDAQ Market News

    ADMA Biologics Announces First Commercial Sales of ASCENIV™

    author_avatar
    NASDAQ Market News

    Agility Health Announces Definitive Agreement to sell U.S.-Based Operations

    GRAND RAPIDS, Mich., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“Agility ...

    author_avatar
    NASDAQ Market News